Column Group

Latest statistics and disclosures from Column Group's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are TNYA, ORIC, Surrozen, RAPT, SGMT, and represent 100.00% of Column Group's stock portfolio.
  • Added to shares of these 1 stock: Surrozen.
  • Reduced shares in these 1 stock: Ngm Biopharmaceuticals (-$29M).
  • Sold out of its position in Ngm Biopharmaceuticals.
  • Column Group was a net seller of stock by $-27M.
  • Column Group has $71M in assets under management (AUM), dropping by -55.60%.
  • Central Index Key (CIK): 0001833486

Tip: Access up to 7 years of quarterly data

Positions held by Column Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Column Group

Column Group holds 6 positions in its portfolio as reported in the June 2024 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Tenaya Therapeutics (TNYA) 40.9 $29M 9.4M 3.10
 View chart
Oric Pharmaceuticals (ORIC) 35.1 $25M 3.5M 7.07
 View chart
Surrozen 12.4 $8.9M +31% 810k 10.95
 View chart
Rapt Therapeutics (RAPT) 11.5 $8.2M 2.7M 3.05
 View chart
Sagimet Biosciences Inc-a (SGMT) 0.1 $59k 17k 3.42
 View chart
Revolution Medicines (RVMD) 0.0 $1.8k 46.00 38.80
 View chart

Past Filings by Column Group

SEC 13F filings are viewable for Column Group going back to 2020